52 related articles for article (PubMed ID: 31867282)
21. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic Adenocarcinoma, Version 1.2019.
Tempero MA; Malafa MP; Chiorean EG; Czito B; Scaife C; Narang AK; Fountzilas C; Wolpin BM; Al-Hawary M; Asbun H; Behrman SW; Benson AB; Binder E; Cardin DB; Cha C; Chung V; Dillhoff M; Dotan E; Ferrone CR; Fisher G; Hardacre J; Hawkins WG; Ko AH; LoConte N; Lowy AM; Moravek C; Nakakura EK; O'Reilly EM; Obando J; Reddy S; Thayer S; Wolff RA; Burns JL; Zuccarino-Catania G
J Natl Compr Canc Netw; 2019 Mar; 17(3):202-210. PubMed ID: 30865919
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic Cancer Lymph Node Resection Revisited: A Novel Calculation of Number of Lymph Nodes Required.
Arrington AK; Price ET; Golisch K; Riall TS
J Am Coll Surg; 2019 Apr; 228(4):662-669. PubMed ID: 30677528
[TBL] [Abstract][Full Text] [Related]
24. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
25. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study.
Jang JY; Kang JS; Han Y; Heo JS; Choi SH; Choi DW; Park SJ; Han SS; Yoon DS; Park JS; Yu HC; Kang KJ; Kim SG; Lee H; Kwon W; Yoon YS; Han HS; Kim SW
J Hepatobiliary Pancreat Sci; 2017 Jul; 24(7):426-433. PubMed ID: 28514000
[TBL] [Abstract][Full Text] [Related]
27. The More the Better-Lower Rate of Stage Migration and Better Survival in Patients With Retrieval of 20 or More Regional Lymph Nodes in Pancreatic Cancer: A Population-Based Propensity Score Matched and Trend SEER Analysis.
Warschkow R; Widmann B; Beutner U; Marti L; Steffen T; Schiesser M; Schmied BM
Pancreas; 2017; 46(5):648-657. PubMed ID: 28196023
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.
Elshaer M; Gravante G; Kosmin M; Riaz A; Al-Bahrani A
Ann R Coll Surg Engl; 2017 Feb; 99(2):101-106. PubMed ID: 27869496
[TBL] [Abstract][Full Text] [Related]
29. Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer.
Eskander MF; de Geus SW; Kasumova GG; Ng SC; Al-Refaie W; Ayata G; Tseng JF
Surgery; 2017 Apr; 161(4):968-976. PubMed ID: 27865602
[TBL] [Abstract][Full Text] [Related]
30. Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?
Lahat G; Lubezky N; Gerstenhaber F; Nizri E; Gysi M; Rozenek M; Goichman Y; Nachmany I; Nakache R; Wolf I; Klausner JM
World J Surg Oncol; 2016 Sep; 14(1):254. PubMed ID: 27687517
[TBL] [Abstract][Full Text] [Related]
31. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers.
Lidsky ME; Sun Z; Nussbaum DP; Adam MA; Speicher PJ; Blazer DG
Ann Surg; 2017 Aug; 266(2):333-338. PubMed ID: 27429020
[TBL] [Abstract][Full Text] [Related]
32. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
Allen PJ; Kuk D; Castillo CF; Basturk O; Wolfgang CL; Cameron JL; Lillemoe KD; Ferrone CR; Morales-Oyarvide V; He J; Weiss MJ; Hruban RH; Gönen M; Klimstra DS; Mino-Kenudson M
Ann Surg; 2017 Jan; 265(1):185-191. PubMed ID: 27163957
[TBL] [Abstract][Full Text] [Related]
33. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
Tol JA; Gouma DJ; Bassi C; Dervenis C; Montorsi M; Adham M; Andrén-Sandberg A; Asbun HJ; Bockhorn M; Büchler MW; Conlon KC; Fernández-Cruz L; Fingerhut A; Friess H; Hartwig W; Izbicki JR; Lillemoe KD; Milicevic MN; Neoptolemos JP; Shrikhande SV; Vollmer CM; Yeo CJ; Charnley RM;
Surgery; 2014 Sep; 156(3):591-600. PubMed ID: 25061003
[TBL] [Abstract][Full Text] [Related]
34. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma.
Valsangkar NP; Bush DM; Michaelson JS; Ferrone CR; Wargo JA; Lillemoe KD; Fernández-del Castillo C; Warshaw AL; Thayer SP
J Gastrointest Surg; 2013 Feb; 17(2):257-66. PubMed ID: 23229885
[TBL] [Abstract][Full Text] [Related]
35. Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.
Shamseddine AI; Mukherji D; Melki C; Elias E; Eloubeidi M; Dimassi H; Khalife M; Abou-Alfa G; O'Reilly E; Faraj W
Am J Clin Oncol; 2014 Feb; 37(1):13-8. PubMed ID: 23111358
[TBL] [Abstract][Full Text] [Related]
36. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.
Huebner M; Kendrick M; Reid-Lombardo KM; Que F; Therneau T; Qin R; Donohue J; Nagorney D; Farnell M; Sarr M
J Gastrointest Surg; 2012 May; 16(5):920-6. PubMed ID: 22421988
[TBL] [Abstract][Full Text] [Related]
37. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial.
Nimura Y; Nagino M; Takao S; Takada T; Miyazaki K; Kawarada Y; Miyagawa S; Yamaguchi A; Ishiyama S; Takeda Y; Sakoda K; Kinoshita T; Yasui K; Shimada H; Katoh H
J Hepatobiliary Pancreat Sci; 2012 May; 19(3):230-41. PubMed ID: 22038501
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers.
Massucco P; Ribero D; Sgotto E; Mellano A; Muratore A; Capussotti L
Ann Surg Oncol; 2009 Dec; 16(12):3323-32. PubMed ID: 19777195
[TBL] [Abstract][Full Text] [Related]
39. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
40. A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a meta-analysis of 1909 patients.
Iqbal N; Lovegrove RE; Tilney HS; Abraham AT; Bhattacharya S; Tekkis PP; Kocher HM
Eur J Surg Oncol; 2009 Jan; 35(1):79-86. PubMed ID: 18356005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
